APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bovine Mastitis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bovine Mastitis Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchBovine Mastitis Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Bovine Mastitis Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Bovine Mastitis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bovine Mastitis Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bovine Mastitis Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bovine Mastitis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bovine Mastitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bovine Mastitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bovine Mastitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bovine Mastitis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bovine Mastitis include Zoetis, Bayer, West Way Health, MSD Animal Health, Elanco, Ceva and Boehringer Ingelheim International, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bovine Mastitis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bovine Mastitis, also provides the revenue of main regions and countries. Of the upcoming market potential for Bovine Mastitis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bovine Mastitis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bovine Mastitis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bovine Mastitis revenue, projected growth trends, production technology, application and end-user industry.

Bovine Mastitis Segment by Company

Zoetis

Bayer

West Way Health

MSD Animal Health

Elanco

Ceva

Boehringer Ingelheim International

Bovine Mastitis Segment by Type

Antibiotics

Others

Bovine Mastitis Segment by Application

Lactating Period

Dry Period

Bovine Mastitis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Mastitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bovine Mastitis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Mastitis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bovine Mastitis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bovine Mastitis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bovine Mastitis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bovine Mastitis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antibiotics Major Player Table 3. Others Major Player Table 4. Global Bovine Mastitis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Lactating Period Major Player Table 6. Dry Period Major Player Table 7. Bovine Mastitis Industry Trends Table 8. Bovine Mastitis Industry Drivers Table 9. Bovine Mastitis Industry Opportunities and Challenges Table 10. Bovine Mastitis Industry Restraints Table 11. Global Bovine Mastitis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Bovine Mastitis Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Bovine Mastitis Market Share by Region (2021-2026) Table 14. Global Bovine Mastitis Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Bovine Mastitis Market Share by Region (2027-2032) Table 16. Global Bovine Mastitis Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Bovine Mastitis Revenue Market Share by Players (2021-2026) Table 18. Global Bovine Mastitis Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Bovine Mastitis Key Players Headquarters & Area Served Table 20. Global Bovine Mastitis Players, Product Type & Application Table 21. Global Bovine Mastitis Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Bovine Mastitis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Bovine Mastitis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bovine Mastitis Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Bovine Mastitis Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Bovine Mastitis Revenue Market Share by Type (2021-2026) Table 28. Global Bovine Mastitis Revenue Market Share by Type (2027-2032) Table 29. Global Bovine Mastitis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Bovine Mastitis Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Bovine Mastitis Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Bovine Mastitis Revenue Market Share by Application (2021-2026) Table 33. Global Bovine Mastitis Revenue Market Share by Application (2027-2032) Table 34. Zoetis Company Information Table 35. Zoetis Business Overview Table 36. Zoetis Bovine Mastitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Zoetis Bovine Mastitis Product Portfolio Table 38. Zoetis Recent Development Table 39. Bayer Company Information Table 40. Bayer Business Overview Table 41. Bayer Bovine Mastitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Bayer Bovine Mastitis Product Portfolio Table 43. Bayer Recent Development Table 44. West Way Health Company Information Table 45. West Way Health Business Overview Table 46. West Way Health Bovine Mastitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. West Way Health Bovine Mastitis Product Portfolio Table 48. West Way Health Recent Development Table 49. MSD Animal Health Company Information Table 50. MSD Animal Health Business Overview Table 51. MSD Animal Health Bovine Mastitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. MSD Animal Health Bovine Mastitis Product Portfolio Table 53. MSD Animal Health Recent Development Table 54. Elanco Company Information Table 55. Elanco Business Overview Table 56. Elanco Bovine Mastitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Elanco Bovine Mastitis Product Portfolio Table 58. Elanco Recent Development Table 59. Ceva Company Information Table 60. Ceva Business Overview Table 61. Ceva Bovine Mastitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Ceva Bovine Mastitis Product Portfolio Table 63. Ceva Recent Development Table 64. Boehringer Ingelheim International Company Information Table 65. Boehringer Ingelheim International Business Overview Table 66. Boehringer Ingelheim International Bovine Mastitis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Boehringer Ingelheim International Bovine Mastitis Product Portfolio Table 68. Boehringer Ingelheim International Recent Development Table 69. North America Bovine Mastitis Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Bovine Mastitis Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Bovine Mastitis Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Bovine Mastitis Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Bovine Mastitis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Bovine Mastitis Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Bovine Mastitis Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Bovine Mastitis Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Bovine Mastitis Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Bovine Mastitis Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Bovine Mastitis Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Bovine Mastitis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Bovine Mastitis Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Bovine Mastitis Revenue by Country (US$ Million) & (2027-2032) Table 83. China Bovine Mastitis Revenue by Type (2021-2026) & (US$ Million) Table 84. China Bovine Mastitis Revenue by Type (2027-2032) & (US$ Million) Table 85. China Bovine Mastitis Revenue by Application (2021-2026) & (US$ Million) Table 86. China Bovine Mastitis Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Bovine Mastitis Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Bovine Mastitis Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Bovine Mastitis Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Bovine Mastitis Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Bovine Mastitis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Bovine Mastitis Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Bovine Mastitis Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Bovine Mastitis Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Bovine Mastitis Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Bovine Mastitis Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Bovine Mastitis Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Bovine Mastitis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Bovine Mastitis Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Bovine Mastitis Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Bovine Mastitis Image Figure 2. Global Bovine Mastitis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bovine Mastitis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antibiotics Image Figure 5. Others Image Figure 6. Global Bovine Mastitis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bovine Mastitis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Lactating Period Image Figure 9. Dry Period Image Figure 10. Global Bovine Mastitis Market Size (US$ Million) & (2021-2032) Figure 11. Global Bovine Mastitis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Bovine Mastitis Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Bovine Mastitis Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Bovine Mastitis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bovine Mastitis Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Bovine Mastitis Revenue Market Share by Type (2021-2032) Figure 18. Global Bovine Mastitis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Bovine Mastitis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Bovine Mastitis Revenue Market Share by Application (2021-2032) Figure 21. North America Bovine Mastitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Bovine Mastitis Revenue Share by Type (2021-2032) Figure 23. North America Bovine Mastitis Revenue Share by Application (2021-2032) Figure 24. North America Bovine Mastitis Revenue Share by Country (2021-2032) Figure 25. United States Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Bovine Mastitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Bovine Mastitis Revenue Share by Type (2021-2032) Figure 30. Europe Bovine Mastitis Revenue Share by Application (2021-2032) Figure 31. Europe Bovine Mastitis Revenue Share by Country (2021-2032) Figure 32. Germany Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Bovine Mastitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Bovine Mastitis Revenue Share by Type (2021-2032) Figure 42. China Bovine Mastitis Revenue Share by Application (2021-2032) Figure 43. Asia Bovine Mastitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Bovine Mastitis Revenue Share by Type (2021-2032) Figure 45. Asia Bovine Mastitis Revenue Share by Application (2021-2032) Figure 46. Asia Bovine Mastitis Revenue Share by Region (2021-2032) Figure 47. Japan Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Bovine Mastitis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Bovine Mastitis Revenue Share by Type (2021-2032) Figure 55. SAMEA Bovine Mastitis Revenue Share by Application (2021-2032) Figure 56. SAMEA Bovine Mastitis Revenue Share by Country (2021-2032) Figure 57. Brazil Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Bovine Mastitis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Others
Applications
  • Lactating Period
  • Dry Period
Companies covered
  • Zoetis
  • Bayer
  • West Way Health
  • MSD Animal Health
  • Elanco
  • Ceva
  • Boehringer Ingelheim International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bovine Mastitis Market by Type
  3. 1.2.1 Global Bovine Mastitis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antibiotics
  5. 1.2.3 Others
  6. 1.3 Bovine Mastitis Market by Application
  7. 1.3.1 Global Bovine Mastitis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Lactating Period
  9. 1.3.3 Dry Period
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Bovine Mastitis Market Dynamics
  1. 2.1 Bovine Mastitis Industry Trends
  2. 2.2 Bovine Mastitis Industry Drivers
  3. 2.3 Bovine Mastitis Industry Opportunities and Challenges
  4. 2.4 Bovine Mastitis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bovine Mastitis Market Perspective (2021-2032)
  2. 3.2 Global Bovine Mastitis Growth Trends by Region
  3. 3.2.1 Global Bovine Mastitis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bovine Mastitis Market Size by Region (2021-2026)
  5. 3.2.3 Global Bovine Mastitis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bovine Mastitis Revenue by Players
  2. 4.1.1 Global Bovine Mastitis Revenue by Players (2021-2026)
  3. 4.1.2 Global Bovine Mastitis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bovine Mastitis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bovine Mastitis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bovine Mastitis Key Players Headquarters & Area Served
  7. 4.4 Global Bovine Mastitis Players, Product Type & Application
  8. 4.5 Global Bovine Mastitis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bovine Mastitis Market CR5 and HHI
  11. 4.6.3 2025 Bovine Mastitis Tier 1, Tier 2, and Tier 3
5 Bovine Mastitis Market Size by Type
  1. 5.1 Global Bovine Mastitis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bovine Mastitis Revenue by Type (2021-2032)
  3. 5.3 Global Bovine Mastitis Revenue Market Share by Type (2021-2032)
6 Bovine Mastitis Market Size by Application
  1. 6.1 Global Bovine Mastitis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bovine Mastitis Revenue by Application (2021-2032)
  3. 6.3 Global Bovine Mastitis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Bovine Mastitis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Bovine Mastitis Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Bovine Mastitis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Bovine Mastitis Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 West Way Health
  14. 7.3.1 West Way Health Company Information
  15. 7.3.2 West Way Health Business Overview
  16. 7.3.3 West Way Health Bovine Mastitis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 West Way Health Bovine Mastitis Product Portfolio
  18. 7.3.5 West Way Health Recent Developments
  19. 7.4 MSD Animal Health
  20. 7.4.1 MSD Animal Health Company Information
  21. 7.4.2 MSD Animal Health Business Overview
  22. 7.4.3 MSD Animal Health Bovine Mastitis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 MSD Animal Health Bovine Mastitis Product Portfolio
  24. 7.4.5 MSD Animal Health Recent Developments
  25. 7.5 Elanco
  26. 7.5.1 Elanco Company Information
  27. 7.5.2 Elanco Business Overview
  28. 7.5.3 Elanco Bovine Mastitis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Elanco Bovine Mastitis Product Portfolio
  30. 7.5.5 Elanco Recent Developments
  31. 7.6 Ceva
  32. 7.6.1 Ceva Company Information
  33. 7.6.2 Ceva Business Overview
  34. 7.6.3 Ceva Bovine Mastitis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Ceva Bovine Mastitis Product Portfolio
  36. 7.6.5 Ceva Recent Developments
  37. 7.7 Boehringer Ingelheim International
  38. 7.7.1 Boehringer Ingelheim International Company Information
  39. 7.7.2 Boehringer Ingelheim International Business Overview
  40. 7.7.3 Boehringer Ingelheim International Bovine Mastitis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Boehringer Ingelheim International Bovine Mastitis Product Portfolio
  42. 7.7.5 Boehringer Ingelheim International Recent Developments
8 North America
  1. 8.1 North America Bovine Mastitis Revenue (2021-2032)
  2. 8.2 North America Bovine Mastitis Revenue by Type (2021-2032)
  3. 8.2.1 North America Bovine Mastitis Revenue by Type (2021-2026)
  4. 8.2.2 North America Bovine Mastitis Revenue by Type (2027-2032)
  5. 8.3 North America Bovine Mastitis Revenue Share by Type (2021-2032)
  6. 8.4 North America Bovine Mastitis Revenue by Application (2021-2032)
  7. 8.4.1 North America Bovine Mastitis Revenue by Application (2021-2026)
  8. 8.4.2 North America Bovine Mastitis Revenue by Application (2027-2032)
  9. 8.5 North America Bovine Mastitis Revenue Share by Application (2021-2032)
  10. 8.6 North America Bovine Mastitis Revenue by Country
  11. 8.6.1 North America Bovine Mastitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bovine Mastitis Revenue by Country (2021-2026)
  13. 8.6.3 North America Bovine Mastitis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Bovine Mastitis Revenue (2021-2032)
  2. 9.2 Europe Bovine Mastitis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bovine Mastitis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bovine Mastitis Revenue by Type (2027-2032)
  5. 9.3 Europe Bovine Mastitis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bovine Mastitis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bovine Mastitis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bovine Mastitis Revenue by Application (2027-2032)
  9. 9.5 Europe Bovine Mastitis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bovine Mastitis Revenue by Country
  11. 9.6.1 Europe Bovine Mastitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bovine Mastitis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bovine Mastitis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Bovine Mastitis Revenue (2021-2032)
  2. 10.2 China Bovine Mastitis Revenue by Type (2021-2032)
  3. 10.2.1 China Bovine Mastitis Revenue by Type (2021-2026)
  4. 10.2.2 China Bovine Mastitis Revenue by Type (2027-2032)
  5. 10.3 China Bovine Mastitis Revenue Share by Type (2021-2032)
  6. 10.4 China Bovine Mastitis Revenue by Application (2021-2032)
  7. 10.4.1 China Bovine Mastitis Revenue by Application (2021-2026)
  8. 10.4.2 China Bovine Mastitis Revenue by Application (2027-2032)
  9. 10.5 China Bovine Mastitis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bovine Mastitis Revenue (2021-2032)
  2. 11.2 Asia Bovine Mastitis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bovine Mastitis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bovine Mastitis Revenue by Type (2027-2032)
  5. 11.3 Asia Bovine Mastitis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bovine Mastitis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bovine Mastitis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bovine Mastitis Revenue by Application (2027-2032)
  9. 11.5 Asia Bovine Mastitis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bovine Mastitis Revenue by Country
  11. 11.6.1 Asia Bovine Mastitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bovine Mastitis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bovine Mastitis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bovine Mastitis Revenue (2021-2032)
  2. 12.2 SAMEA Bovine Mastitis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bovine Mastitis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bovine Mastitis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bovine Mastitis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bovine Mastitis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bovine Mastitis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bovine Mastitis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bovine Mastitis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bovine Mastitis Revenue by Country
  11. 12.6.1 SAMEA Bovine Mastitis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bovine Mastitis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bovine Mastitis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst